欧洲三国二次骨折预防中抗骨质疏松治疗启动率的长期趋势:丹麦、加泰罗尼亚和英国多国队列研究
该多国队列研究纳入丹麦、加泰罗尼亚和英国2005至2015年间50岁及以上首次脆性骨折患者共648,369例,评估骨折后1年内未启动抗骨质疏松药物治疗的比例(治疗缺口)。结果显示丹麦治疗缺口稳定在约88-90%,加泰罗尼亚从80%升至88%,英国治疗缺口先降后升(始终不低于63%),且男性缺口大于女性。结论认为二次骨折预防的治疗缺口仍然巨大,近年趋势可能恶化。
要点
- 丹麦2005-2015年骨折后1年抗骨质疏松治疗缺口稳定在约88-90%。
- 加泰罗尼亚治疗缺口从80%上升至88%。
- 英国治疗缺口先降后升,始终不低于63%,研究末期呈上升趋势。
核心结论
- 尽管反复呼吁改善二次骨折预防,骨折后抗骨质疏松治疗缺口仍然巨大,且近年趋势可能恶化。
研究设计与样本
- 多国队列研究,纳入丹麦、加泰罗尼亚和英国三个行政健康数据库2005至2015年50岁及以上首次脆性骨折的男女性患者。
- 共纳入648,369例骨折患者,平均年龄70.2-78.9岁,男性占22.2-31.7%。
- 治疗缺口定义为首次骨折后1年内未接受抗骨质疏松药物治疗的患者比例。
主要发现
- 丹麦治疗缺口在整个2005至2015年期间稳定在约88-90%。
- 加泰罗尼亚治疗缺口从80%增加至88%。
- 英国治疗缺口初期下降但从未小于63%,研究末期转为上升。
- 治疗缺口在男性中比女性更明显。
临床怎么用
- 骨折后1年内启动抗骨质疏松治疗的比例极低,需系统改进二次骨折预防流程。
- 男性骨折患者的治疗缺口更大,应特别关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed. INTRODUCTION: Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015. METHODS: This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture. RESULTS: A total of 648,369 fracture patients were included. Mean age 70.2-78.9 years; 22.2-31.7% were men. In Denmark, the treatment gap was stable at approximately 88-90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap-though never smaller than 63%-was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women. CONCLUSION: Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years.
引用
- Skjødt MK, Khalid S, Ernst M, et al. Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom. Osteoporos Int. 2020. PMID: 32185437. doi:10.1007/s00198-020-05358-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。